Professor Susan Wong
Prosiectau fel Prif Ymchwiliwr
1 o 5
- A new biology of clinical outcome in immune-mediated disease (01.11.2019 - 31.10.2021)
- A window into the pancreas in type 1 diabetes (01.10.2019 - 31.07.2021)
- B cell chemokines in type 1 diabetes mellitus (01.08.2018 - 31.12.2022)
- B cells in newly diagnosed type 1 diabetes (01.03.2012 - 31.07.2016)
- Can modulating T-cell across inflamed endothelium prevent type 1 diabetes? (01.03.2012 - 28.02.2013)
Prosiectau fel Cyd-Ymchwiliwr
1 o 2
- Microneedle delivery of antigen-specific immunotherapy for type 1 diabetes (01.10.2014 - 30.09.2018)
- Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger, smarter, faster (01.05.2019 - 30.04.2023)
- Gold Nanoparticles coupled with selective PAMP ligands to deliver antigen specific immunotherapy (01.10.2016 - 30.06.2019)
- Microneedle arrays to deliver antigen specific immunotherapy (01.10.2014 - 31.12.2019)
- Phenotyping the Brecon Cohort of childhood-onset type 1 diabetes to identify those at risk of adverse long-term outcomes who may in future merit immunotherapeutic intervention at diagnosis (01.03.2016 - 31.12.2016)
Thomson Reuters Deutschland GmbH
Zur Giesserei 2
D-76227 Karlsruhe | Germany